CD79B (Polatuzumab Biosimilar) antibody

Catalog No. ABIN7538759

The Humanized Monoclonal anti-CD79B (Polatuzumab Biosimilar) antibody has been validated for ELISA and FACS. It is suitable to detect CD79B (Polatuzumab Biosimilar) in samples from Human.

Quick Overview for CD79B (Polatuzumab Biosimilar) antibody (ABIN7538759)

Target: CD79B (Polatuzumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD79B (Polatuzumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-CD79B (Polatuzumab Biosimilar) Antibody

Purpose: Anti-CD79B(polatuzumab biosimilar) mAb

Characteristics: RO5541077, RG-7596

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CD79B (Polatuzumab Biosimilar)

Target: CD79B (Polatuzumab Biosimilar)

Target Type: Biosimilar

Background: B29,IGB

UniProt: P40259